• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身磁共振成像,包括在睾丸癌患者随访中的扩散加权成像。

Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.

作者信息

Mosavi Firas, Laurell Anna, Ahlström Håkan

机构信息

a Section of Radiology, Department of Radiology , Oncology and Radiation Science, Uppsala University Hospital , Uppsala , Sweden.

b Section of Oncology, Department of Radiology , Oncology and Radiation Science, Uppsala University Hospital , Uppsala , Sweden.

出版信息

Acta Oncol. 2015 Nov;54(10):1763-9. doi: 10.3109/0284186X.2015.1043027. Epub 2015 May 15.

DOI:10.3109/0284186X.2015.1043027
PMID:25975210
Abstract

BACKGROUND

Whole body (WB) magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI) has become increasingly utilized in cancer imaging, yet the clinical utility of these techniques in follow-up of testicular cancer patients has not been evaluated. The purpose of this study was to evaluate the feasibility of WB MRI with continuous table movement (CTM) technique, including multistep DWI in follow-up of patients with testicular cancer.

PATIENTS AND METHODS

WB MRI including DWI was performed in follow-up of 71 consecutive patients (median age, 37 years; range 19-84) with histologically confirmed testicular cancer. WB MRI protocol included axial T1-Dixon and T2-BLADE sequences using CTM technique. Furthermore, multi-step DWI was performed using b-value 50 and 1000 s/mm(2). One criterion for feasibility was patient tolerance and satisfactory image quality. Another criterion was the accuracy in detection of any pathological mass, compared to standard of reference. Signal intensity in DWI was used for evaluation of residual mass activity. Clinical, laboratory and imaging follow-up were applied as standard of reference for the evaluation of WB MRI.

RESULTS

WB MRI was tolerated in nearly all patients (69/71 patients, 97%) and the image quality was satisfactory. Metal artifacts deteriorated the image quality in six patients, but it did not influence the overall results. No case of clinical relapse was observed during the follow-up time. There was a good agreement between conventional WB MRI and standard of reference in all patients. Three patients showed residual masses and DWI signal was not restricted in these patients. Furthermore, DWI showed abnormally high signal intensity in a normal-sized retroperitoneal lymph node indicating metastasis. The subsequent (18)F-FDG PET/CT could verify the finding.

CONCLUSION

WB MRI with CTM technique including multi-step DWI is feasible in follow-up of patients with testicular cancer. DWI may contribute to important added-value data to conventional MRI sequences regarding the activity of residual masses.

摘要

背景

全身(WB)磁共振成像(MRI),包括扩散加权成像(DWI),在癌症成像中的应用越来越广泛,但这些技术在睾丸癌患者随访中的临床实用性尚未得到评估。本研究的目的是评估采用连续床移动(CTM)技术的WB MRI,包括多步DWI在睾丸癌患者随访中的可行性。

患者与方法

对71例经组织学证实的睾丸癌患者(中位年龄37岁;范围19 - 84岁)进行随访,均接受了包括DWI的WB MRI检查。WB MRI方案包括采用CTM技术的轴位T1 - Dixon和T2 - BLADE序列。此外,使用b值50和1000 s/mm²进行多步DWI。可行性的一个标准是患者耐受性和满意的图像质量。另一个标准是与参考标准相比,检测任何病理性肿块的准确性。DWI中的信号强度用于评估残留肿块的活性。临床、实验室和影像学随访作为评估WB MRI的参考标准。

结果

几乎所有患者(69/71例患者,97%)都能耐受WB MRI,图像质量令人满意。6例患者的金属伪影使图像质量下降,但未影响总体结果。随访期间未观察到临床复发病例。所有患者的传统WB MRI与参考标准之间具有良好的一致性。3例患者显示有残留肿块,这些患者的DWI信号未受限。此外,DWI在一个正常大小的腹膜后淋巴结中显示出异常高的信号强度,提示转移。随后的(18)F - FDG PET/CT证实了这一发现。

结论

采用CTM技术包括多步DWI的WB MRI在睾丸癌患者随访中是可行的。DWI可能为传统MRI序列提供有关残留肿块活性的重要附加价值数据。

相似文献

1
Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.全身磁共振成像,包括在睾丸癌患者随访中的扩散加权成像。
Acta Oncol. 2015 Nov;54(10):1763-9. doi: 10.3109/0284186X.2015.1043027. Epub 2015 May 15.
2
Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?全身扩散加权成像与 FDG-PET 检测非小细胞肺癌:孰优孰劣?
Magn Reson Imaging. 2010 Jun;28(5):613-20. doi: 10.1016/j.mri.2010.02.009. Epub 2010 Apr 24.
3
Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.全身扩散加权成像:在淋巴瘤初始诊断中对全身 MRI 的附加价值。
AJR Am J Roentgenol. 2011 Sep;197(3):W384-91. doi: 10.2214/AJR.10.5692.
4
Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.全身磁共振扩散加权成像在检测恶性转移瘤中的临床价值
Chin Med Sci J. 2009 Jun;24(2):112-6. doi: 10.1016/s1001-9294(09)60072-9.
5
Whole-Body Diffusion Imaging Applying Simultaneous Multi-Slice Excitation.应用同步多层激发的全身扩散成像
Rofo. 2016 Apr;188(4):381-8. doi: 10.1055/s-0035-1567032. Epub 2016 Jan 27.
6
Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.全身磁共振弥散加权序列在疑似卵巢癌患者分期中的临床可行性研究:与 CT 和 FDG-PET/CT 的比较。
Eur Radiol. 2014 Apr;24(4):889-901. doi: 10.1007/s00330-013-3083-8. Epub 2013 Dec 11.
7
Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.全身扩散加权磁共振成像(WB-DWI/MRI)在胃癌诊断、分期和随访中的准确性,与 CT 相比:一项初步研究。
BMC Med Imaging. 2021 Feb 5;21(1):18. doi: 10.1186/s12880-021-00550-2.
8
Diagnostic Performance of Whole-Body Diffusion-Weighted Imaging Compared to PET-CT Plus Brain MRI in Staging Clinically Resectable Lung Cancer.全身弥散加权成像与PET-CT联合脑MRI在临床可切除肺癌分期中的诊断效能比较
Asian Pac J Cancer Prev. 2016;17(6):2775-80.
9
Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.全身扩散加权 MRI 检测妊娠期女性癌症患者原发肿瘤、淋巴结和远处转移的可行性:一项初步研究。
Eur Radiol. 2018 May;28(5):1862-1874. doi: 10.1007/s00330-017-5126-z. Epub 2017 Dec 7.
10
Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.新诊断的淋巴瘤:全身 T1 加权、STIR 和弥散加权 MRI 与 18F-FDG PET/CT 的初步结果比较。
AJR Am J Roentgenol. 2011 Mar;196(3):662-9. doi: 10.2214/AJR.10.4743.

引用本文的文献

1
Abdominopelvic imaging in the follow-up of testicular germ-cell tumors in adults: recommendations of the Scrotal and Penile Imaging Working Group of the European Society of Urogenital Radiology.成人睾丸生殖细胞肿瘤随访中的腹盆腔影像学检查:欧洲泌尿生殖放射学会阴囊与阴茎影像学工作组的建议
Eur Radiol. 2025 Jan 25. doi: 10.1007/s00330-025-11380-z.
2
Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures.核医学成像在非精原细胞瘤生殖细胞肿瘤中的应用:从过去的失败中吸取的教训。
Cancer Imaging. 2024 Nov 18;24(1):156. doi: 10.1186/s40644-024-00794-5.
3
Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it.
全身 MRI 在转移疾病和骨髓瘤中的现状与未来:如何以及为何您将使用它。
Skeletal Radiol. 2024 Sep;53(9):1815-1831. doi: 10.1007/s00256-024-04723-2. Epub 2024 Jul 15.
4
Technical Advancements in Abdominal Diffusion-weighted Imaging.腹部弥散加权成像技术进展。
Magn Reson Med Sci. 2023 Apr 1;22(2):191-208. doi: 10.2463/mrms.rev.2022-0107. Epub 2023 Mar 15.
5
Magnetic resonance imaging study of normal cranial bone marrow conversion at high altitude.高海拔地区正常颅骨骨髓转化的磁共振成像研究
Quant Imaging Med Surg. 2022 Jun;12(6):3126-3137. doi: 10.21037/qims-21-740.
6
Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study.全身 MRI 能否替代 CT 在转移性睾丸癌治疗中的应用?一项前瞻性、非劣效性研究。
J Cancer Res Clin Oncol. 2023 Mar;149(3):1221-1230. doi: 10.1007/s00432-022-03996-1. Epub 2022 Apr 7.
7
Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell Cancer.全身磁共振成像在检测睾丸生殖细胞癌患者淋巴结转移中的应用
Life (Basel). 2022 Jan 29;12(2):212. doi: 10.3390/life12020212.
8
Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review.磁共振成像能否替代传统的计算机断层扫描用于睾丸癌患者的随访?一项系统评价。
World J Urol. 2022 Dec;40(12):2843-2852. doi: 10.1007/s00345-022-03931-6. Epub 2022 Jan 17.
9
Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging.当代选择与未来展望:三个突出睾丸癌成像挑战的实例。
World J Urol. 2022 Feb;40(2):307-315. doi: 10.1007/s00345-021-03856-6. Epub 2021 Nov 15.
10
The utility of diffusion-weighted whole-body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma.背景体素信号抑制的扩散加权全身成像在检测生殖细胞癌转移灶中的应用。
IJU Case Rep. 2021 Jun 16;4(5):285-288. doi: 10.1002/iju5.12327. eCollection 2021 Sep.